Company profile
Ticker
BSIIU, BSIIW, BSII
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Gemphire Therapeutics Inc.
SEC CIK
Corporate docs
BSIIU stock data
Latest filings (excl ownership)
10-Q
2024 Q2
Quarterly report
7 Oct 24
8-K
Other Events
7 Oct 24
8-K
Black Spade Acquisition Ii Co
2 Oct 24
8-K
Index to Financial Statement
5 Sep 24
8-K
Black Spade Acquisition II Co Announces Pricing Of $150 Million Initial Public Offering
30 Aug 24
424B4
Prospectus supplement with pricing info
29 Aug 24
CERT
Certification of approval for exchange listing
26 Aug 24
EFFECT
Notice of effectiveness
26 Aug 24
8-A12B
Registration of securities on exchange
23 Aug 24
S-1/A
IPO registration (amended)
20 Aug 24
Financial summary
Quarter (USD) | Jun 24 | |
---|---|---|
Revenue | ||
Cost of revenue | ||
Operating income | ||
Operating margin | ||
Net income | ||
Net profit margin | ||
Cash on hand | ||
Change in cash | ||
Diluted EPS |